DR. CONSTANTINE F HARRIS M.D. NPI 1720077548

NPI Details

DR. Constantine F Harris, M.D. is an urology in Wyomissing, PA with 27 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Constantine F Harris, M.D. NPI is 1720077548. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA
Graduation Year:1999

The provider's business location address is:

1320 BROADCASTING RD
STE 200
WYOMISSING, PA
ZIP 19610-222
Phone: (610) 372-8995
Fax: (610) 685-5984

The NPI 1720077548 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Urinalysis, manual test (HCPCS:81002)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Insertion of implant in urethra within prostate gland using an endoscope, each additional implant (HCPCS:52442)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Biopsy of prostate gland (HCPCS:55700)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Shock wave crushing of kidney stones (HCPCS:50590)
• Insertion of implant in urethra within prostate gland using an endoscope, 1 implant (HCPCS:52441)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm (HCPCS:52224)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 10/14/2005 and was last updated on 8/26/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.